Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)-Reference-Cited by-同舟云学术

Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)

Published:2021-09 Issue:3 Volume:100 Page:684-696
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Perrone Ronald D.,Abebe Kaleab Z.,Watnick Terry J.,Althouse Andrew D.,Hallows Kenneth R.,Lalama Christina M.,Miskulin Dana C.,Seliger Stephen L.,Tao Cheng,Harris Peter C.,Bae Kyongtae Ty

Publisher

Elsevier BV

Subject

Nephrology

Reference36 articles.

1. Autosomal dominant polycystic kidney disease;Cornec-Le Gall;Lancet,2019

2. Blood pressure in early autosomal dominant polycystic kidney disease;Schrier;N Engl J Med,2014

3. Angiotensin blockade in late autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2014

4. A practical guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan;Chebib;J Am Soc Nephrol,2018

5. Tolvaptan in patients with autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2012

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease – A Randomized Control Trial;Indian Journal of Nephrology;2024-08-29

2. Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease;Nutrients;2024-08-06

3. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease;Biomolecules;2024-07-07

4. Metformin for preventing the progression of chronic kidney disease;Cochrane Database of Systematic Reviews;2024-06-04

5. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23